Shares have lagged the market this year, partly due to some public image and regulatory issues. DexCom's stock could drop even more if results falls short of revenue expectations. Whatever happens on ...
Dexcom is facing scrutiny and class-action lawsuits over alleged safety and accuracy issues with its G7 monitor.
The company’s technology utilizes data from various sensors to monitor critical assets, aiming to minimize downtime and reduce maintenance costs. With a current market capitalization of $46.7 million ...
Stifel projected that the 15-day sensor could enhance DexCom’s gross margin in 2026, potentially contributing to year-over-year EBITDA margin expansion. The firm acknowledged certain risks, including ...
Hosted on MSN
Xpeng G6 Charging Port Location and Design Overview
This video provides an overview of the charging port location and design on the Xpeng G6, highlighting its seamless integration into the vehicle’s bodywork. The segment demonstrates how the flap opens ...
The Federal Circuit upheld an administrative tribunal’s decision to nix six claims from a DexCom Inc. patent covering implantable sensors used to monitor patients’ blood glucose levels. DexCom sued ...
Dexcom is recalling 19 models of its continuous glucose monitoring receivers due to a speaker malfunction that could prevent alerts for dangerous blood sugar levels. The affected devices are models ...
Dexcom started the recall on May 12. For the G7, more than 600,000 receivers were affected globally, while for the G6, more than 36,800 devices were affected. Tens of thousands of receivers for Dexcom ...
We recently published a list of 11 Best Medical Device Stocks to Buy Now. In this article, we are going to take a look at where DexCom, Inc. (NASDAQ:DXCM) stands against other best medical device ...
DexCom has a well-established record of introducing the most precise sensors for use in its continuous glucose monitors. On the strength of its technology, DexCom has captured an impressive slice of ...
Dexcom has won a clearance from the FDA for its longest-lasting continuous glucose monitor, a 15-day version of its flagship G7 sensor. The new system, which boosts wear time up from the previous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results